About this trial
The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
Eligibility criteria
Qualifiers
Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring
Subject must voluntarily sign and date an IRB approved informed consent form
Subjects with diagnosis of acne scarring recorded over the past 6 months
Able to read, understand and voluntarily provide written informed consent.
Disqualifiers
Subjects does not have the capacity to consent to the study
subject underwent any acne scar treatments in the past 6 months prior to enrollment in the study
Subject has active papulopustular or cystic acne within the past 6 months.
Any history of keloidal scarring.
Trial design
Treatments tested in this trial
- Sciton Halo
Treatment groups
Locations
1Sponsors and collaborators
Albert Einstein College of Medicine
Lead sponsor